Chugai Pharmaceutical Co., Ltd.

TSE:4519 Stock Report

Market Cap: JP¥9.9t

Chugai Pharmaceutical Future Growth

Future criteria checks 3/6

Chugai Pharmaceutical is forecast to grow earnings and revenue by 8% and 4.6% per annum respectively. EPS is expected to grow by 8% per annum. Return on equity is forecast to be 21.4% in 3 years.

Key information

8.0%

Earnings growth rate

8.02%

EPS growth rate

Pharmaceuticals earnings growth8.9%
Revenue growth rate4.6%
Future return on equity21.42%
Analyst coverage

Good

Last updated26 Aug 2025

Recent future growth updates

Chugai Pharmaceutical Co., Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Jul 26
Chugai Pharmaceutical Co., Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Chugai Pharmaceutical Co., Ltd. Just Recorded A 19% EPS Beat: Here's What Analysts Are Forecasting Next

Apr 27
Chugai Pharmaceutical Co., Ltd. Just Recorded A 19% EPS Beat: Here's What Analysts Are Forecasting Next

Chugai Pharmaceutical Co., Ltd. (TSE:4519) Just Released Its Yearly Results And Analysts Are Updating Their Estimates

Feb 03
Chugai Pharmaceutical Co., Ltd. (TSE:4519) Just Released Its Yearly Results And Analysts Are Updating Their Estimates

Chugai Pharmaceutical Co., Ltd. Just Beat Revenue By 12%: Here's What Analysts Think Will Happen Next

Oct 29
Chugai Pharmaceutical Co., Ltd. Just Beat Revenue By 12%: Here's What Analysts Think Will Happen Next

Recent updates

Chugai Pharmaceutical Co., Ltd.'s (TSE:4519) Shareholders Might Be Looking For Exit

Aug 17
Chugai Pharmaceutical Co., Ltd.'s (TSE:4519) Shareholders Might Be Looking For Exit

Chugai Pharmaceutical Co., Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Jul 26
Chugai Pharmaceutical Co., Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

If EPS Growth Is Important To You, Chugai Pharmaceutical (TSE:4519) Presents An Opportunity

Jul 10
If EPS Growth Is Important To You, Chugai Pharmaceutical (TSE:4519) Presents An Opportunity

Chugai Pharmaceutical's (TSE:4519) Upcoming Dividend Will Be Larger Than Last Year's

Jun 10
Chugai Pharmaceutical's (TSE:4519) Upcoming Dividend Will Be Larger Than Last Year's

Chugai Pharmaceutical (TSE:4519) Is Paying Out A Larger Dividend Than Last Year

May 21
Chugai Pharmaceutical (TSE:4519) Is Paying Out A Larger Dividend Than Last Year

Chugai Pharmaceutical Co., Ltd. Just Recorded A 19% EPS Beat: Here's What Analysts Are Forecasting Next

Apr 27
Chugai Pharmaceutical Co., Ltd. Just Recorded A 19% EPS Beat: Here's What Analysts Are Forecasting Next

Chugai Pharmaceutical Co., Ltd.'s (TSE:4519) Business Is Yet to Catch Up With Its Share Price

Apr 25
Chugai Pharmaceutical Co., Ltd.'s (TSE:4519) Business Is Yet to Catch Up With Its Share Price

Calculating The Intrinsic Value Of Chugai Pharmaceutical Co., Ltd. (TSE:4519)

Mar 17
Calculating The Intrinsic Value Of Chugai Pharmaceutical Co., Ltd. (TSE:4519)
User avatar

Accelerating RED Capabilities And Robust Pipeline Will Enhance Future Prospects

Emphasis on RED capabilities and innovative products aims to drive revenue growth and improve net and operating margins.

Chugai Pharmaceutical Co., Ltd. (TSE:4519) Just Released Its Yearly Results And Analysts Are Updating Their Estimates

Feb 03
Chugai Pharmaceutical Co., Ltd. (TSE:4519) Just Released Its Yearly Results And Analysts Are Updating Their Estimates

Chugai Pharmaceutical Co., Ltd.'s (TSE:4519) Share Price Could Signal Some Risk

Dec 23
Chugai Pharmaceutical Co., Ltd.'s (TSE:4519) Share Price Could Signal Some Risk

Calculating The Fair Value Of Chugai Pharmaceutical Co., Ltd. (TSE:4519)

Dec 05
Calculating The Fair Value Of Chugai Pharmaceutical Co., Ltd. (TSE:4519)

Chugai Pharmaceutical's (TSE:4519) Dividend Will Be ¥41.00

Oct 30
Chugai Pharmaceutical's (TSE:4519) Dividend Will Be ¥41.00

Chugai Pharmaceutical Co., Ltd. Just Beat Revenue By 12%: Here's What Analysts Think Will Happen Next

Oct 29
Chugai Pharmaceutical Co., Ltd. Just Beat Revenue By 12%: Here's What Analysts Think Will Happen Next

Chugai Pharmaceutical's (TSE:4519) Dividend Will Be ¥41.00

Oct 15
Chugai Pharmaceutical's (TSE:4519) Dividend Will Be ¥41.00

Should You Be Adding Chugai Pharmaceutical (TSE:4519) To Your Watchlist Today?

Oct 12
Should You Be Adding Chugai Pharmaceutical (TSE:4519) To Your Watchlist Today?

Chugai Pharmaceutical's (TSE:4519) Dividend Will Be ¥41.00

Sep 24
Chugai Pharmaceutical's (TSE:4519) Dividend Will Be ¥41.00

Earnings and Revenue Growth Forecasts

TSE:4519 - Analysts future estimates and past financials data (JPY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20271,370,817511,290446,936513,78312
12/31/20261,280,708463,098406,765476,11713
12/31/20251,233,425434,629333,864473,37413
6/30/20251,196,214395,444378,911462,121N/A
3/31/20251,222,121410,150350,746413,364N/A
12/31/20241,170,611387,317395,500447,600N/A
9/30/20241,142,350386,964349,434419,416N/A
6/30/20241,084,570355,041265,465327,068N/A
3/31/20241,036,076326,373323,991383,090N/A
12/31/20231,111,367325,472350,827409,925N/A
9/30/20231,276,051336,745205,825258,712N/A
6/30/20231,243,437326,969200,169252,605N/A
3/31/20231,211,632316,154252,376299,319N/A
12/31/20221,259,946374,429172,873244,112N/A
9/30/20221,143,716370,791298,989366,072N/A
6/30/20221,205,696389,011339,236422,551N/A
3/31/20221,191,496387,359227,919305,626N/A
12/31/2021999,759302,995206,760279,626N/A
9/30/2021887,919256,462180,866256,890N/A
6/30/2021809,055230,577194,361252,664N/A
3/31/2021776,339210,611165,601246,567N/A
12/31/2020786,946214,733143,646205,035N/A
9/30/2020753,853202,590127,482211,422N/A
6/30/2020734,019190,599108,080196,718N/A
3/31/2020711,320174,062116,245178,610N/A
12/31/2019686,184157,560145,464206,641N/A
9/30/2019662,198139,54383,362160,274N/A
6/30/2019614,949113,07043,280118,955N/A
3/31/2019586,64899,631N/A101,309N/A
12/31/2018579,78792,488N/A119,074N/A
9/30/2018572,99485,857N/A125,700N/A
6/30/2018566,54885,285N/A120,997N/A
3/31/2018556,15982,101N/A127,695N/A
12/31/2017534,19972,713N/A107,623N/A
9/30/2017517,90867,704N/A63,732N/A
6/30/2017497,02358,143N/A67,355N/A
3/31/2017497,35457,592N/A49,230N/A
12/31/2016491,78053,592N/A38,787N/A
9/30/2016492,58456,562N/A40,808N/A
6/30/2016506,19262,537N/A39,670N/A
3/31/2016501,64961,043N/A49,913N/A
12/31/2015498,83961,125N/A62,918N/A
9/30/2015495,45558,897N/A75,502N/A
6/30/2015479,26552,220N/A50,719N/A
3/31/2015454,14746,786N/A54,919N/A
12/31/2014461,10950,980N/A37,034N/A
9/30/2014450,54552,461N/A38,017N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 4519's forecast earnings growth (8% per year) is above the savings rate (0.5%).

Earnings vs Market: 4519's earnings (8% per year) are forecast to grow slower than the JP market (8.2% per year).

High Growth Earnings: 4519's earnings are forecast to grow, but not significantly.

Revenue vs Market: 4519's revenue (4.6% per year) is forecast to grow faster than the JP market (4.3% per year).

High Growth Revenue: 4519's revenue (4.6% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 4519's Return on Equity is forecast to be high in 3 years time (21.4%)

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/08/27 13:35
End of Day Share Price 2025/08/27 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Chugai Pharmaceutical Co., Ltd. is covered by 27 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Atsushi SekiBarclays
Koichi MameganoBofA Global Research
Siti Bte SalikinCFRA Equity Research